cached image

Philip Scheltens, MD PhD

Alzheimer Center VU University Medical Center, Amsterdam, Netherlands 
dementia, MRI, CSF, PET,
"Philip Scheltens"

Mean distance: 16.41 (cluster 44)
Cross-listing: Alzheimer's Tree


Sign in to add mentor
Johan Carel Koetsier grad student 1993 VU Amsterdam
Jaap Valk grad student 1993 VU Amsterdam
 (MR imaging in Alzheimer's disease)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vermunt L, Muniz-Terrera G, Ter Meulen L, et al. (2020) Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Alzheimer's Research & Therapy. 12: 8
Stamate D, Kim M, Proitsi P, et al. (2019) A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimer's & Dementia (New York, N. Y.). 5: 933-938
Dufresne J, Bowden P, Thavarajah T, et al. (2019) The plasma peptides of breast versus ovarian cancer. Clinical Proteomics. 16: 43
Wolters EE, Ossenkoppele R, Golla SS, et al. (2019) Hippocampal [F]flortaucipir BP corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships. Neuroimage. Clinical. 25: 102113
Reimand J, de Wilde A, Teunissen CE, et al. (2019) PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer's Research & Therapy. 11: 100
Reimand J, Groot C, Teunissen CE, et al. (2019) Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers? Journal of Alzheimer's Disease : Jad
Leijenaar JF, Groot C, Sudre CH, et al. (2019) Comorbid amyloid-β pathology affects clinical and imaging features in VCD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Jokinen H, Koikkalainen J, Laakso HM, et al. (2019) Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline. Stroke. STROKEAHA119026170
Scheltens NME, Briels CT, Yaqub M, et al. (2019) Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 492-500
Banning LCP, Janssen EPCJ, Hamel REG, et al. (2019) Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia. Journal of Geriatric Psychiatry and Neurology. 891988719882104
See more...